Protein Microarray Market

The protein microarray market is projected to reach USD 1.78 billion by 2030 from USD 1.00 billion in 2025, at a CAGR of 12.3%. Some of the key factors driving this market’s growth include high-throughput biomarker discovery needs and integration with multi-omics workflows.

Key players in the protein microarray market with a strong footprint include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Agilent Technologies (US), Illumina (US), Merck KGaA (Germany), Qiagen (Netherlands), PerkinElmer, Inc. (US), and Waters Corporation (US). Companies in this market are scaling beyond traditional protein analysis tools into high-throughput, automated platforms covering advanced biochip fabrication, multiplex detection scanners, next-generation protein profiling arrays, and specialized reagents targeting complex signaling networks and multi-omics integration. By expanding production capacity and launching integrated hardware-software ecosystems, key players aim to extend their regional presence across proteome mapping while supporting personalized medicine programs in discovery, translational research, and clinical diagnostics.

In October 2025, Merck (Sigma-Aldrich) launched the Panorama Human Cancer Version 1 Protein Functional Microarray, enhancing high-throughput cancer biomarker screening and protein interaction studies with improved sensitivity for clinical research.

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific (US)

Thermo Fisher Scientific leads the protein microarrays market, combining high-density biochip platforms, automated array printing workflows, and advanced data analysis software to unlock comprehensive insights into protein interactions and biomarker panels. By integrating multiplex immunoassay arrays and proximity-based detection technologies into its life sciences portfolio, the company establishes itself as the premier partner for biopharma and translational researchers seeking scalable, high-plex protein profiling to power precision medicine initiatives.

Danaher Corporation (US)

Danaher Corporation excels as a key protein microarrays market player, leveraging Beckman Coulter's high-throughput array scanners, automated sample handling systems, and Leica Microsystems' advanced imaging software to provide precise multiplex protein profiling and interaction mapping. Through its Cytiva and Pall Life Sciences integration offering specialized biochip consumables and filtration solutions, Danaher positions itself as a comprehensive partner for biopharma developers and clinical researchers pursuing high-density biomarker arrays and precision diagnostic panels.

Agilent Technologies (US)

Agilent Technologies is an important protein microarrays market player, combining high-performance SurePrint array platforms, automated hybridization systems, and advanced microarray scanners to deliver precise multiplex protein profiling and biomarker discovery. Through its SurePlex amplification technology and custom array design services, Agilent positions itself as a trusted partner for biopharma researchers and clinical labs advancing high-throughput protein interaction studies and companion diagnostic development.

Market Ranking

Thermo Fisher Scientific embeds high-density biochip platforms, proximity assays derived from Olink, and concerted printing workflows, thus allowing researchers to transform raw samples into actionable protein interaction data with as few handoffs as possible. Danaher, through Beckman Coulter scanners and Cytiva consumables, provides well-standardized high-throughput array reading and sample preparation solutions that make the compilation of complex protein profiling routine in biopharma and core laboratories. Agilent Technologies complements this with SurePrint microarray systems and Spectrum Mill analytics, equipping laboratories with robust tools for protein quantitation that integrate seamlessly into multi-omics pipelines. Illumina provides deployable bead-based arrays and protein detection linked to sequencing to accelerate biomarker panels and functional screening. Merck KGaA rounds out this field with Sigma-Aldrich nitrocellulose slides, histone peptide arrays, and assay kits that simplify protein-protein interaction studies for discovery teams scaling toward validated diagnostics.

Related Reports:

Protein Microarray Market By Offerings (Products, Services), Type (Biochips, Microarray Instruments), Application (Clinical, Drug Discovery)- Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com